Cargando…
Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia
BACKGROUND: Currently, there are no guidelines for the treatment of rheumatoid arthritis (RA) tailored to the context of the Kingdom of Saudi Arabia (KSA). Adaptation of guidelines accounts for contextual factors and becomes more efficient than de novo guideline development when relevant, good quali...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563247/ https://www.ncbi.nlm.nih.gov/pubmed/37817088 http://dx.doi.org/10.1186/s12874-023-02031-2 |
_version_ | 1785118297573818368 |
---|---|
author | Khabsa, Joanne Yaacoub, Sally Omair, Mohammed A. Al Rayes, Hanan Akl, Elie A. |
author_facet | Khabsa, Joanne Yaacoub, Sally Omair, Mohammed A. Al Rayes, Hanan Akl, Elie A. |
author_sort | Khabsa, Joanne |
collection | PubMed |
description | BACKGROUND: Currently, there are no guidelines for the treatment of rheumatoid arthritis (RA) tailored to the context of the Kingdom of Saudi Arabia (KSA). Adaptation of guidelines accounts for contextual factors and becomes more efficient than de novo guideline development when relevant, good quality, and up-to-date guidelines are available. The objective of this study is to describe the methodology used for the adolopment of the 2021 American College of Rheumatology (ACR) guidelines for the treatment of RA in the KSA. METHODS: We followed the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE)-ADOLOPMENT methodology. The adolopment KSA panel included relevant stakeholders and leading contributors to the original guidelines. We developed a list of five adaptation-relevant prioritization criteria that the panelists applied to the original recommendations. We updated the original evidence profiles with newly published studies identified by the panelists. We constructed Evidence to Decision (EtD) tables including contextual information from the KSA setting. We used the PanelVoice function of GRADEPro Guideline Development Tool (GDT) to obtain the panel’s judgments on the EtD criteria ahead of the panel meeting. Following the meeting, we used the PANELVIEW instrument to obtain the panel’s evaluation of the process. RESULTS: The KSA panel prioritized five recommendations, for which one evidence profile required updating. Out of five adoloped recommendations, two were modified in terms of direction, and one was modified in terms of certainty of the evidence. Criteria driving the modifications in direction were valuation of outcomes, balance of effects, cost, and acceptability. The mean score on the 7-point scale items of the PANELVIEW instrument had an average of 6.47 (SD = 0.18) across all items. CONCLUSION: The GRADE-ADOLOPMENT methodology proved to be efficient. The panel assessed the process and outcome positively. Engagement of stakeholders proved to be important for the success of this project. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-02031-2. |
format | Online Article Text |
id | pubmed-10563247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105632472023-10-11 Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia Khabsa, Joanne Yaacoub, Sally Omair, Mohammed A. Al Rayes, Hanan Akl, Elie A. BMC Med Res Methodol Research BACKGROUND: Currently, there are no guidelines for the treatment of rheumatoid arthritis (RA) tailored to the context of the Kingdom of Saudi Arabia (KSA). Adaptation of guidelines accounts for contextual factors and becomes more efficient than de novo guideline development when relevant, good quality, and up-to-date guidelines are available. The objective of this study is to describe the methodology used for the adolopment of the 2021 American College of Rheumatology (ACR) guidelines for the treatment of RA in the KSA. METHODS: We followed the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE)-ADOLOPMENT methodology. The adolopment KSA panel included relevant stakeholders and leading contributors to the original guidelines. We developed a list of five adaptation-relevant prioritization criteria that the panelists applied to the original recommendations. We updated the original evidence profiles with newly published studies identified by the panelists. We constructed Evidence to Decision (EtD) tables including contextual information from the KSA setting. We used the PanelVoice function of GRADEPro Guideline Development Tool (GDT) to obtain the panel’s judgments on the EtD criteria ahead of the panel meeting. Following the meeting, we used the PANELVIEW instrument to obtain the panel’s evaluation of the process. RESULTS: The KSA panel prioritized five recommendations, for which one evidence profile required updating. Out of five adoloped recommendations, two were modified in terms of direction, and one was modified in terms of certainty of the evidence. Criteria driving the modifications in direction were valuation of outcomes, balance of effects, cost, and acceptability. The mean score on the 7-point scale items of the PANELVIEW instrument had an average of 6.47 (SD = 0.18) across all items. CONCLUSION: The GRADE-ADOLOPMENT methodology proved to be efficient. The panel assessed the process and outcome positively. Engagement of stakeholders proved to be important for the success of this project. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-02031-2. BioMed Central 2023-10-10 /pmc/articles/PMC10563247/ /pubmed/37817088 http://dx.doi.org/10.1186/s12874-023-02031-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Khabsa, Joanne Yaacoub, Sally Omair, Mohammed A. Al Rayes, Hanan Akl, Elie A. Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia |
title | Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia |
title_full | Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia |
title_fullStr | Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia |
title_full_unstemmed | Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia |
title_short | Methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the Kingdom of Saudi Arabia |
title_sort | methodology for the adolopment of recommendations for the treatment of rheumatoid arthritis in the kingdom of saudi arabia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563247/ https://www.ncbi.nlm.nih.gov/pubmed/37817088 http://dx.doi.org/10.1186/s12874-023-02031-2 |
work_keys_str_mv | AT khabsajoanne methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia AT yaacoubsally methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia AT omairmohammeda methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia AT alrayeshanan methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia AT akleliea methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia AT methodologyfortheadolopmentofrecommendationsforthetreatmentofrheumatoidarthritisinthekingdomofsaudiarabia |